2002
DOI: 10.1172/jci0213236
|View full text |Cite
|
Sign up to set email alerts
|

Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
83
0

Year Published

2004
2004
2018
2018

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 107 publications
(88 citation statements)
references
References 38 publications
(37 reference statements)
4
83
0
Order By: Relevance
“…We found that both monocytes and PBLs were able to migrate through the epithelial monolayer and were found in the basal chamber of the Transwell. These in vitro data are consistent with our findings in vivo (5), which show that cells introduced vaginally into HuPBL-SCID mice migrate across the intact reproductive epithelium and can be found in regional lymph nodes within 4 h. The data are also consistent with in vitro findings from Phillips et al demonstrating that monocytes can cross cervical epithelial tissue by migrating between cells (32).…”
Section: Discussionsupporting
confidence: 93%
See 1 more Smart Citation
“…We found that both monocytes and PBLs were able to migrate through the epithelial monolayer and were found in the basal chamber of the Transwell. These in vitro data are consistent with our findings in vivo (5), which show that cells introduced vaginally into HuPBL-SCID mice migrate across the intact reproductive epithelium and can be found in regional lymph nodes within 4 h. The data are also consistent with in vitro findings from Phillips et al demonstrating that monocytes can cross cervical epithelial tissue by migrating between cells (32).…”
Section: Discussionsupporting
confidence: 93%
“…To determine the extent to which ICAM-1 is involved in the process of vaginal HIV-1 transmission in vivo, we administered anti-ICAM-1 Abs to HuPBL-SCID mice exposed vaginally to HIV-1-infected PBMCs as described (5). Briefly, anti-ICAM-1 or appropriate isotype control Abs (0.4 g in 10 l of PBS with 1% BSA) were administered vaginally followed 5 min later by 1 ϫ 10 6 human PBMCs, of which between 1 and 5% were infected with HIV-1 Ba-L as determined by LD-PCR.…”
Section: Anti-icam-1 Abs Inhibit Transepithelial Transmission Of Cellmentioning
confidence: 99%
“…In addition, ␤-cyclodextrin, a compound analogous to M␤CD and which selectively extracts cholesterol from plasma membranes, has been shown to cause hypolipidemic effects in genetically hypercholesterolimic rats when fed orally [35]. Very recently, topical application of ␤-cyclodextrin has been shown to block the transmission of cell-associated HIV-1 [36]. This is based on earlier observations on the involvement of cholesterol in the infection of HIV type 1 [30,31].…”
Section: Discussionmentioning
confidence: 99%
“…BCD has been given intravaginally to mice at a 3% concentration in PBS (10), to rabbits at a 5% concentration in a gel formulation (5), and to women at 70% concentration in a gel formulation daily for 1 month (J. E. K. Hildreth, unpublished results) without pathological effects. To better understand the effects of short-term BCD exposure on individual cell types, we tested the toxicity of a 2-hour incubation with BCD on three cell lines: Caco-2, a human intestinal epithelial cell line; GHOST-Hi5, derived from human osteosarcoma cells; and HeLa, a human cervical epithelial cell line (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…BCD (3%) in phosphate-buffered saline (PBS) was shown to efficiently inhibit intravaginal transmission of cell-associated HIV-1 in a SCID-Hu mouse model of infection (10). Other attractive microbicidal characteristics of BCD were its high solubility in water, its lack of color or odor, and its low cost.…”
mentioning
confidence: 99%